nodes	percent_of_prediction	percent_of_DWPC	metapath
Bacitracin—IDE—nipple—breast cancer	0.0294	0.0845	CbGeAlD
Bacitracin—A2M—mammary gland—breast cancer	0.0273	0.0786	CbGeAlD
Bacitracin—A2M—nipple—breast cancer	0.0226	0.065	CbGeAlD
Bacitracin—A2M—embryo—breast cancer	0.0187	0.0537	CbGeAlD
Bacitracin—IDE—uterus—breast cancer	0.0163	0.047	CbGeAlD
Bacitracin—IDE—adipose tissue—breast cancer	0.016	0.046	CbGeAlD
Bacitracin—A2M—epithelium—breast cancer	0.0152	0.0438	CbGeAlD
Bacitracin—IDE—female reproductive system—breast cancer	0.0147	0.0423	CbGeAlD
Bacitracin—A2M—skin of body—breast cancer	0.0145	0.0416	CbGeAlD
Bacitracin—IDE—adrenal gland—breast cancer	0.0143	0.0412	CbGeAlD
Bacitracin—IDE—bone marrow—breast cancer	0.0139	0.0399	CbGeAlD
Bacitracin—A2M—endometrium—breast cancer	0.0136	0.0393	CbGeAlD
Bacitracin—IDE—female gonad—breast cancer	0.0134	0.0384	CbGeAlD
Bacitracin—A2M—uterus—breast cancer	0.0126	0.0362	CbGeAlD
Bacitracin—IDE—endocrine gland—breast cancer	0.0124	0.0358	CbGeAlD
Bacitracin—A2M—pituitary gland—breast cancer	0.0124	0.0355	CbGeAlD
Bacitracin—A2M—adipose tissue—breast cancer	0.0123	0.0354	CbGeAlD
Bacitracin—A2M—female reproductive system—breast cancer	0.0113	0.0325	CbGeAlD
Bacitracin—A2M—adrenal gland—breast cancer	0.011	0.0317	CbGeAlD
Bacitracin—A2M—bone marrow—breast cancer	0.0107	0.0307	CbGeAlD
Bacitracin—A2M—female gonad—breast cancer	0.0103	0.0296	CbGeAlD
Bacitracin—A2M—endocrine gland—breast cancer	0.00957	0.0275	CbGeAlD
Bacitracin—IDE—lymph node—breast cancer	0.00859	0.0247	CbGeAlD
Bacitracin—A2M—lymph node—breast cancer	0.00661	0.019	CbGeAlD
Bacitracin—Pain—Carboplatin—breast cancer	0.00339	0.0204	CcSEcCtD
Bacitracin—Azotaemia—Methotrexate—breast cancer	0.00335	0.0202	CcSEcCtD
Bacitracin—Nausea—Fluoxymesterone—breast cancer	0.00312	0.0188	CcSEcCtD
Bacitracin—Pain—Fulvestrant—breast cancer	0.00294	0.0177	CcSEcCtD
Bacitracin—Pain—Toremifene—breast cancer	0.0029	0.0174	CcSEcCtD
Bacitracin—Pain—Exemestane—breast cancer	0.00255	0.0153	CcSEcCtD
Bacitracin—Pain—Ixabepilone—breast cancer	0.00241	0.0145	CcSEcCtD
Bacitracin—Vomiting—Lapatinib—breast cancer	0.00237	0.0143	CcSEcCtD
Bacitracin—Rash—Lapatinib—breast cancer	0.00235	0.0142	CcSEcCtD
Bacitracin—Dermatitis—Lapatinib—breast cancer	0.00235	0.0141	CcSEcCtD
Bacitracin—Pain—Letrozole—breast cancer	0.00227	0.0136	CcSEcCtD
Bacitracin—Pain—Anastrozole—breast cancer	0.00227	0.0136	CcSEcCtD
Bacitracin—Albuminuria—Epirubicin—breast cancer	0.00224	0.0135	CcSEcCtD
Bacitracin—Nausea—Lapatinib—breast cancer	0.00222	0.0133	CcSEcCtD
Bacitracin—Vomiting—Fulvestrant—breast cancer	0.00218	0.0131	CcSEcCtD
Bacitracin—Rash—Fulvestrant—breast cancer	0.00216	0.013	CcSEcCtD
Bacitracin—Dermatitis—Fulvestrant—breast cancer	0.00216	0.013	CcSEcCtD
Bacitracin—Vomiting—Toremifene—breast cancer	0.00215	0.013	CcSEcCtD
Bacitracin—Pain—Raloxifene—breast cancer	0.00215	0.0129	CcSEcCtD
Bacitracin—Rash—Toremifene—breast cancer	0.00214	0.0128	CcSEcCtD
Bacitracin—Dermatitis—Toremifene—breast cancer	0.00213	0.0128	CcSEcCtD
Bacitracin—Albuminuria—Doxorubicin—breast cancer	0.00207	0.0125	CcSEcCtD
Bacitracin—Nausea—Fulvestrant—breast cancer	0.00204	0.0123	CcSEcCtD
Bacitracin—Nausea—Toremifene—breast cancer	0.00201	0.0121	CcSEcCtD
Bacitracin—Vomiting—Exemestane—breast cancer	0.0019	0.0114	CcSEcCtD
Bacitracin—Rash—Exemestane—breast cancer	0.00188	0.0113	CcSEcCtD
Bacitracin—Dermatitis—Exemestane—breast cancer	0.00188	0.0113	CcSEcCtD
Bacitracin—Vomiting—Ixabepilone—breast cancer	0.00179	0.0108	CcSEcCtD
Bacitracin—Rash—Ixabepilone—breast cancer	0.00177	0.0107	CcSEcCtD
Bacitracin—Dermatitis—Ixabepilone—breast cancer	0.00177	0.0107	CcSEcCtD
Bacitracin—Nausea—Exemestane—breast cancer	0.00177	0.0107	CcSEcCtD
Bacitracin—Pain—Chlorambucil—breast cancer	0.00174	0.0105	CcSEcCtD
Bacitracin—Vomiting—Anastrozole—breast cancer	0.00168	0.0101	CcSEcCtD
Bacitracin—Vomiting—Letrozole—breast cancer	0.00168	0.0101	CcSEcCtD
Bacitracin—Nausea—Ixabepilone—breast cancer	0.00167	0.0101	CcSEcCtD
Bacitracin—Rash—Anastrozole—breast cancer	0.00167	0.01	CcSEcCtD
Bacitracin—Rash—Letrozole—breast cancer	0.00167	0.01	CcSEcCtD
Bacitracin—Dermatitis—Anastrozole—breast cancer	0.00167	0.01	CcSEcCtD
Bacitracin—Dermatitis—Letrozole—breast cancer	0.00167	0.01	CcSEcCtD
Bacitracin—Vomiting—Raloxifene—breast cancer	0.0016	0.00962	CcSEcCtD
Bacitracin—Vomiting—Idarubicin—breast cancer	0.0016	0.00962	CcSEcCtD
Bacitracin—Pain—Vinblastine—breast cancer	0.0016	0.0096	CcSEcCtD
Bacitracin—Rash—Idarubicin—breast cancer	0.00159	0.00954	CcSEcCtD
Bacitracin—Rash—Raloxifene—breast cancer	0.00159	0.00954	CcSEcCtD
Bacitracin—Dermatitis—Idarubicin—breast cancer	0.00158	0.00953	CcSEcCtD
Bacitracin—Dermatitis—Raloxifene—breast cancer	0.00158	0.00953	CcSEcCtD
Bacitracin—Nausea—Anastrozole—breast cancer	0.00157	0.00947	CcSEcCtD
Bacitracin—Nausea—Letrozole—breast cancer	0.00157	0.00947	CcSEcCtD
Bacitracin—Pain—Tamoxifen—breast cancer	0.00155	0.00933	CcSEcCtD
Bacitracin—Pain—Melphalan—breast cancer	0.00152	0.00913	CcSEcCtD
Bacitracin—Nausea—Idarubicin—breast cancer	0.00149	0.00898	CcSEcCtD
Bacitracin—Nausea—Raloxifene—breast cancer	0.00149	0.00898	CcSEcCtD
Bacitracin—Pain—Goserelin—breast cancer	0.00148	0.00891	CcSEcCtD
Bacitracin—Pain—Vinorelbine—breast cancer	0.00133	0.00798	CcSEcCtD
Bacitracin—Vomiting—Chlorambucil—breast cancer	0.0013	0.00779	CcSEcCtD
Bacitracin—Pain—Thiotepa—breast cancer	0.00127	0.00762	CcSEcCtD
Bacitracin—Nausea—Chlorambucil—breast cancer	0.00121	0.00728	CcSEcCtD
Bacitracin—Vomiting—Vinblastine—breast cancer	0.00119	0.00714	CcSEcCtD
Bacitracin—Vomiting—Tamoxifen—breast cancer	0.00115	0.00693	CcSEcCtD
Bacitracin—Rash—Tamoxifen—breast cancer	0.00114	0.00688	CcSEcCtD
Bacitracin—Dermatitis—Tamoxifen—breast cancer	0.00114	0.00687	CcSEcCtD
Bacitracin—Vomiting—Melphalan—breast cancer	0.00113	0.00679	CcSEcCtD
Bacitracin—Rash—Melphalan—breast cancer	0.00112	0.00673	CcSEcCtD
Bacitracin—Dermatitis—Melphalan—breast cancer	0.00112	0.00673	CcSEcCtD
Bacitracin—Nausea—Vinblastine—breast cancer	0.00111	0.00667	CcSEcCtD
Bacitracin—Vomiting—Goserelin—breast cancer	0.0011	0.00662	CcSEcCtD
Bacitracin—Pain—Mitoxantrone—breast cancer	0.00109	0.00658	CcSEcCtD
Bacitracin—Pain—Irinotecan—breast cancer	0.00109	0.00658	CcSEcCtD
Bacitracin—Rash—Goserelin—breast cancer	0.00109	0.00657	CcSEcCtD
Bacitracin—Dermatitis—Goserelin—breast cancer	0.00109	0.00656	CcSEcCtD
Bacitracin—Nausea—Tamoxifen—breast cancer	0.00108	0.00648	CcSEcCtD
Bacitracin—Pain—Gemcitabine—breast cancer	0.00107	0.00641	CcSEcCtD
Bacitracin—Nausea—Melphalan—breast cancer	0.00105	0.00634	CcSEcCtD
Bacitracin—Pain—Fluorouracil—breast cancer	0.00105	0.0063	CcSEcCtD
Bacitracin—Nausea—Goserelin—breast cancer	0.00103	0.00619	CcSEcCtD
Bacitracin—Vomiting—Vinorelbine—breast cancer	0.000986	0.00593	CcSEcCtD
Bacitracin—Rash—Vinorelbine—breast cancer	0.000978	0.00588	CcSEcCtD
Bacitracin—Dermatitis—Vinorelbine—breast cancer	0.000977	0.00588	CcSEcCtD
Bacitracin—Vomiting—Thiotepa—breast cancer	0.000942	0.00566	CcSEcCtD
Bacitracin—Rash—Thiotepa—breast cancer	0.000934	0.00562	CcSEcCtD
Bacitracin—Dermatitis—Thiotepa—breast cancer	0.000933	0.00561	CcSEcCtD
Bacitracin—Nausea—Vinorelbine—breast cancer	0.000921	0.00554	CcSEcCtD
Bacitracin—Pain—Paclitaxel—breast cancer	0.000892	0.00537	CcSEcCtD
Bacitracin—Nausea—Thiotepa—breast cancer	0.00088	0.00529	CcSEcCtD
Bacitracin—Vomiting—Irinotecan—breast cancer	0.000813	0.00489	CcSEcCtD
Bacitracin—Vomiting—Mitoxantrone—breast cancer	0.000813	0.00489	CcSEcCtD
Bacitracin—Rash—Irinotecan—breast cancer	0.000807	0.00485	CcSEcCtD
Bacitracin—Rash—Mitoxantrone—breast cancer	0.000807	0.00485	CcSEcCtD
Bacitracin—Dermatitis—Irinotecan—breast cancer	0.000806	0.00485	CcSEcCtD
Bacitracin—Dermatitis—Mitoxantrone—breast cancer	0.000806	0.00485	CcSEcCtD
Bacitracin—Vomiting—Gemcitabine—breast cancer	0.000792	0.00477	CcSEcCtD
Bacitracin—Rash—Gemcitabine—breast cancer	0.000786	0.00473	CcSEcCtD
Bacitracin—Dermatitis—Gemcitabine—breast cancer	0.000785	0.00472	CcSEcCtD
Bacitracin—Vomiting—Fluorouracil—breast cancer	0.000779	0.00469	CcSEcCtD
Bacitracin—Rash—Fluorouracil—breast cancer	0.000773	0.00465	CcSEcCtD
Bacitracin—Dermatitis—Fluorouracil—breast cancer	0.000772	0.00464	CcSEcCtD
Bacitracin—Nausea—Mitoxantrone—breast cancer	0.00076	0.00457	CcSEcCtD
Bacitracin—Nausea—Irinotecan—breast cancer	0.00076	0.00457	CcSEcCtD
Bacitracin—Pain—Docetaxel—breast cancer	0.000756	0.00455	CcSEcCtD
Bacitracin—Nausea—Gemcitabine—breast cancer	0.00074	0.00445	CcSEcCtD
Bacitracin—Pain—Capecitabine—breast cancer	0.000732	0.0044	CcSEcCtD
Bacitracin—Nausea—Fluorouracil—breast cancer	0.000728	0.00438	CcSEcCtD
Bacitracin—Vomiting—Paclitaxel—breast cancer	0.000663	0.00399	CcSEcCtD
Bacitracin—Rash—Paclitaxel—breast cancer	0.000658	0.00396	CcSEcCtD
Bacitracin—Dermatitis—Paclitaxel—breast cancer	0.000657	0.00395	CcSEcCtD
Bacitracin—Nausea—Paclitaxel—breast cancer	0.00062	0.00373	CcSEcCtD
Bacitracin—Vomiting—Docetaxel—breast cancer	0.000562	0.00338	CcSEcCtD
Bacitracin—Rash—Docetaxel—breast cancer	0.000558	0.00335	CcSEcCtD
Bacitracin—Dermatitis—Docetaxel—breast cancer	0.000557	0.00335	CcSEcCtD
Bacitracin—A2M—Metabolism—LDHB—breast cancer	0.000549	0.00113	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—IL2—breast cancer	0.000546	0.00112	CbGpPWpGaD
Bacitracin—Pain—Methotrexate—breast cancer	0.000545	0.00328	CcSEcCtD
Bacitracin—Vomiting—Capecitabine—breast cancer	0.000544	0.00327	CcSEcCtD
Bacitracin—Rash—Capecitabine—breast cancer	0.00054	0.00325	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—RSPO3—breast cancer	0.00054	0.00111	CbGpPWpGaD
Bacitracin—Dermatitis—Capecitabine—breast cancer	0.000539	0.00324	CcSEcCtD
Bacitracin—A2M—Hemostasis—HGF—breast cancer	0.000539	0.00111	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—PLA2G4A—breast cancer	0.000539	0.00111	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—CSF2—breast cancer	0.000533	0.0011	CbGpPWpGaD
Bacitracin—Nausea—Docetaxel—breast cancer	0.000525	0.00316	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—WNT10B—breast cancer	0.000525	0.00108	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—WWOX—breast cancer	0.000525	0.00108	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ABCC1—breast cancer	0.00052	0.00107	CbGpPWpGaD
Bacitracin—A2M—Metabolism—HMMR—breast cancer	0.00052	0.00107	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GSTA3—breast cancer	0.00052	0.00107	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CCL27—breast cancer	0.000512	0.00105	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—INHBB—breast cancer	0.000512	0.00105	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PDE2A—breast cancer	0.000512	0.00105	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CXCL3—breast cancer	0.000512	0.00105	CbGpPWpGaD
Bacitracin—Pain—Epirubicin—breast cancer	0.00051	0.00307	CcSEcCtD
Bacitracin—Nausea—Capecitabine—breast cancer	0.000509	0.00306	CcSEcCtD
Bacitracin—A2M—Metabolism—PPARGC1B—breast cancer	0.000504	0.00104	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	0.000491	0.00101	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	0.000491	0.00101	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—DLL4—breast cancer	0.000488	0.001	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—BMPR2—breast cancer	0.000488	0.001	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—SRC—breast cancer	0.000477	0.000981	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CA9—breast cancer	0.000476	0.000979	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GSTA4—breast cancer	0.000476	0.000979	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—CASP3—breast cancer	0.000475	0.000976	CbGpPWpGaD
Bacitracin—Pain—Doxorubicin—breast cancer	0.000472	0.00284	CcSEcCtD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—GPX1—breast cancer	0.00047	0.000967	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CDH5—breast cancer	0.000468	0.000963	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	0.000465	0.000957	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—VEGFA—breast cancer	0.000464	0.000955	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GSTA2—breast cancer	0.000464	0.000954	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GPX2—breast cancer	0.000464	0.000954	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—SFRP2—breast cancer	0.000459	0.000944	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—MMP1—breast cancer	0.000458	0.000943	CbGpPWpGaD
Bacitracin—A2M—Metabolism—SULT1A1—breast cancer	0.000458	0.000942	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GPX4—breast cancer	0.000458	0.000942	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PRLR—breast cancer	0.000451	0.000927	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—PLAU—breast cancer	0.00045	0.000925	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—CDK2—breast cancer	0.00045	0.000925	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—MMP9—breast cancer	0.000449	0.000923	CbGpPWpGaD
Bacitracin—A2M—Metabolism—IDH1—breast cancer	0.000448	0.000921	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GSTA1—breast cancer	0.000448	0.000921	CbGpPWpGaD
Bacitracin—A2M—Metabolism—NAT2—breast cancer	0.000442	0.00091	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—CAV1—breast cancer	0.000439	0.000904	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—MAPK3—breast cancer	0.000439	0.000904	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—VCP—breast cancer	0.000435	0.000895	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—GLI2—breast cancer	0.000435	0.000895	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—LEPR—breast cancer	0.000428	0.000881	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—TGFB1—breast cancer	0.000426	0.000877	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—FN1—breast cancer	0.000418	0.00086	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—NOS2—breast cancer	0.000413	0.00085	CbGpPWpGaD
Bacitracin—Vomiting—Methotrexate—breast cancer	0.000405	0.00244	CcSEcCtD
Bacitracin—Rash—Methotrexate—breast cancer	0.000402	0.00242	CcSEcCtD
Bacitracin—Dermatitis—Methotrexate—breast cancer	0.000402	0.00241	CcSEcCtD
Bacitracin—A2M—Hemostasis—PIK3CG—breast cancer	0.0004	0.000823	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—CAV1—breast cancer	0.0004	0.000823	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—ARHGDIA—breast cancer	0.000398	0.000819	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—EGF—breast cancer	0.000396	0.000814	CbGpPWpGaD
Bacitracin—A2M—Metabolism—MED12—breast cancer	0.000388	0.000798	CbGpPWpGaD
Bacitracin—A2M—Metabolism—DPYD—breast cancer	0.000388	0.000798	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—FST—breast cancer	0.000388	0.000798	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—HEY2—breast cancer	0.000383	0.000788	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ALDOA—breast cancer	0.000382	0.000786	CbGpPWpGaD
Bacitracin—Vomiting—Epirubicin—breast cancer	0.000379	0.00228	CcSEcCtD
Bacitracin—Nausea—Methotrexate—breast cancer	0.000379	0.00228	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—RPS6KB2—breast cancer	0.000379	0.000779	CbGpPWpGaD
Bacitracin—Rash—Epirubicin—breast cancer	0.000376	0.00226	CcSEcCtD
Bacitracin—Dermatitis—Epirubicin—breast cancer	0.000376	0.00226	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—RGS2—breast cancer	0.000374	0.00077	CbGpPWpGaD
Bacitracin—A2M—Metabolism—NCOA3—breast cancer	0.000371	0.000763	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CCL20—breast cancer	0.00037	0.000761	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—TGFB1—breast cancer	0.00037	0.000761	CbGpPWpGaD
Bacitracin—A2M—Metabolism—SLC2A2—breast cancer	0.000368	0.000757	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—IGF1—breast cancer	0.000366	0.000754	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—AKT2—breast cancer	0.000366	0.000753	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	0.000364	0.00075	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—PIK3CA—breast cancer	0.000363	0.000746	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CPT1A—breast cancer	0.000361	0.000742	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ABCG2—breast cancer	0.000361	0.000742	CbGpPWpGaD
Bacitracin—A2M—Metabolism—MTR—breast cancer	0.000361	0.000742	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—LPAR1—breast cancer	0.000358	0.000737	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—TLE3—breast cancer	0.000358	0.000737	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—HEY1—breast cancer	0.000355	0.00073	CbGpPWpGaD
Bacitracin—Nausea—Epirubicin—breast cancer	0.000354	0.00213	CcSEcCtD
Bacitracin—A2M—Metabolism—HPGDS—breast cancer	0.000354	0.000728	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—PIK3CD—breast cancer	0.000352	0.000724	CbGpPWpGaD
Bacitracin—A2M—Metabolism—HBA1—breast cancer	0.000352	0.000723	CbGpPWpGaD
Bacitracin—Vomiting—Doxorubicin—breast cancer	0.000351	0.00211	CcSEcCtD
Bacitracin—A2M—Hemostasis—SERPINE1—breast cancer	0.000348	0.000716	CbGpPWpGaD
Bacitracin—Rash—Doxorubicin—breast cancer	0.000348	0.00209	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—DLL1—breast cancer	0.000348	0.000716	CbGpPWpGaD
Bacitracin—Dermatitis—Doxorubicin—breast cancer	0.000348	0.00209	CcSEcCtD
Bacitracin—A2M—Hemostasis—ALB—breast cancer	0.000347	0.000715	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ACHE—breast cancer	0.000343	0.000706	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GSTT1—breast cancer	0.000343	0.000706	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—HIST1H2BC—breast cancer	0.000341	0.000702	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—HIST1H2BK—breast cancer	0.000341	0.000702	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PDE4D—breast cancer	0.000338	0.000696	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—GRB7—breast cancer	0.000338	0.000696	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—TAB2—breast cancer	0.000333	0.000684	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—NOS3—breast cancer	0.000332	0.000683	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CNR2—breast cancer	0.00033	0.000678	CbGpPWpGaD
Bacitracin—Nausea—Doxorubicin—breast cancer	0.000328	0.00197	CcSEcCtD
Bacitracin—A2M—Metabolism—CYP17A1—breast cancer	0.000325	0.000668	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—DKK1—breast cancer	0.000322	0.000662	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PTGS1—breast cancer	0.000322	0.000661	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ENO1—breast cancer	0.000322	0.000661	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	0.00032	0.000659	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—VEGFC—breast cancer	0.000319	0.000657	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—ALB—breast cancer	0.000316	0.000651	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CYP2D6—breast cancer	0.000315	0.000649	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—JAG2—breast cancer	0.000315	0.000647	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—RAF1—breast cancer	0.000314	0.000646	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—WNT1—breast cancer	0.00031	0.000638	CbGpPWpGaD
Bacitracin—A2M—Metabolism—NCOA2—breast cancer	0.000309	0.000637	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—PIK3CB—breast cancer	0.000307	0.000631	CbGpPWpGaD
Bacitracin—A2M—Metabolism—FASN—breast cancer	0.0003	0.000617	CbGpPWpGaD
Bacitracin—A2M—Metabolism—BCHE—breast cancer	0.000299	0.000615	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—AKT1—breast cancer	0.000296	0.00061	CbGpPWpGaD
Bacitracin—A2M—Metabolism—SLC5A5—breast cancer	0.000295	0.000607	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—NOTCH4—breast cancer	0.000294	0.000605	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—GZMB—breast cancer	0.000292	0.000601	CbGpPWpGaD
Bacitracin—A2M—Metabolism—NQO1—breast cancer	0.000285	0.000587	CbGpPWpGaD
Bacitracin—A2M—Metabolism—SLC2A1—breast cancer	0.000285	0.000587	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—AGTR2—breast cancer	0.000284	0.000583	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CXCL2—breast cancer	0.000284	0.000583	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—IL2—breast cancer	0.000282	0.000579	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—BMP2—breast cancer	0.00028	0.000577	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PTHLH—breast cancer	0.00028	0.000577	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	0.000279	0.000574	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CYP3A4—breast cancer	0.000278	0.000572	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	0.000277	0.000569	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CYP1B1—breast cancer	0.000273	0.000562	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—EDNRB—breast cancer	0.000272	0.000559	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PGR—breast cancer	0.000269	0.000553	CbGpPWpGaD
Bacitracin—A2M—Metabolism—HSP90AA1—breast cancer	0.000268	0.000551	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—THBS1—breast cancer	0.000268	0.00055	CbGpPWpGaD
Bacitracin—A2M—Metabolism—NCOA1—breast cancer	0.000261	0.000536	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CYP19A1—breast cancer	0.000257	0.000529	CbGpPWpGaD
Bacitracin—A2M—Metabolism—STK11—breast cancer	0.000257	0.000529	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—FLT1—breast cancer	0.000255	0.000525	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—FGF3—breast cancer	0.000254	0.000523	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—SQSTM1—breast cancer	0.000254	0.000523	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—JAG1—breast cancer	0.000251	0.000516	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PARP1—breast cancer	0.00025	0.000514	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—NOTCH3—breast cancer	0.00025	0.000514	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CALCA—breast cancer	0.000247	0.000508	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—SRC—breast cancer	0.000246	0.000506	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—RPS6—breast cancer	0.000244	0.000502	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—FGF4—breast cancer	0.000242	0.000498	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PTEN—breast cancer	0.000241	0.000496	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CXCL12—breast cancer	0.000241	0.000496	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CXCR4—breast cancer	0.000241	0.000496	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—VEGFA—breast cancer	0.000239	0.000492	CbGpPWpGaD
Bacitracin—A2M—Metabolism—COMT—breast cancer	0.000239	0.000492	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GSTP1—breast cancer	0.000238	0.000489	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PAK1—breast cancer	0.000237	0.000487	CbGpPWpGaD
Bacitracin—A2M—Metabolism—HMOX1—breast cancer	0.000235	0.000482	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ITPR1—breast cancer	0.000234	0.000481	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—TCF7L2—breast cancer	0.000233	0.000478	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—MAPK3—breast cancer	0.000226	0.000466	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ABCB1—breast cancer	0.000225	0.000463	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—NOTCH2—breast cancer	0.000224	0.000461	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—HSP90AA1—breast cancer	0.000224	0.000461	CbGpPWpGaD
Bacitracin—A2M—Metabolism—TYMS—breast cancer	0.000221	0.000455	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—TGFB1—breast cancer	0.00022	0.000452	CbGpPWpGaD
Bacitracin—A2M—Metabolism—NCOR1—breast cancer	0.000219	0.00045	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GSTM1—breast cancer	0.000219	0.00045	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PLA2G4A—breast cancer	0.000219	0.00045	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—AGTR1—breast cancer	0.000218	0.000449	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PRL—breast cancer	0.000218	0.000449	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—STK11—breast cancer	0.000215	0.000442	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—ADAM10—breast cancer	0.000215	0.000442	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PLG—breast cancer	0.000213	0.000437	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GPX1—breast cancer	0.000209	0.000431	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—FGF10—breast cancer	0.000209	0.00043	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CYP1A1—breast cancer	0.000207	0.000426	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ERCC2—breast cancer	0.000205	0.000423	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—KRAS—breast cancer	0.000203	0.000419	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PDGFA—breast cancer	0.000202	0.000415	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—TGFBR2—breast cancer	0.000199	0.000409	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—ITPR1—breast cancer	0.000196	0.000403	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—ERBB4—breast cancer	0.000194	0.0004	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—STAT5A—breast cancer	0.000194	0.0004	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MMP3—breast cancer	0.000194	0.0004	CbGpPWpGaD
Bacitracin—A2M—Metabolism—MTHFR—breast cancer	0.000193	0.000397	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—SMAD4—breast cancer	0.000188	0.000387	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—IGF1R—breast cancer	0.000187	0.000385	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—PIK3CA—breast cancer	0.000187	0.000385	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—HES1—breast cancer	0.000184	0.000378	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—NCOR1—breast cancer	0.000183	0.000376	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PLA2G4A—breast cancer	0.000183	0.000376	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—TP53—breast cancer	0.000181	0.000372	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CSF2—breast cancer	0.000181	0.000372	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—FGF1—breast cancer	0.000181	0.000372	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—NRG1—breast cancer	0.000179	0.000369	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CAV1—breast cancer	0.000178	0.000366	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—H2AFX—breast cancer	0.000178	0.000366	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—E2F1—breast cancer	0.000177	0.000364	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—HRAS—breast cancer	0.000173	0.000356	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	0.00017	0.00035	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—SPP1—breast cancer	0.00017	0.000349	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—ERBB3—breast cancer	0.000168	0.000346	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—FGFR2—breast cancer	0.000168	0.000345	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PIK3CG—breast cancer	0.000162	0.000334	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—TERT—breast cancer	0.000161	0.000331	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—FGFR1—breast cancer	0.000156	0.000322	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—HIF1A—breast cancer	0.000154	0.000317	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—AKT1—breast cancer	0.000153	0.000314	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—LEP—breast cancer	0.00015	0.000309	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CAV1—breast cancer	0.000149	0.000306	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—KDR—breast cancer	0.000147	0.000303	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—ESR1—breast cancer	0.000144	0.000295	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PIK3CD—breast cancer	0.000143	0.000293	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—FN1—breast cancer	0.000142	0.000292	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ALB—breast cancer	0.000141	0.00029	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—NFKBIA—breast cancer	0.00014	0.000288	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—NOTCH1—breast cancer	0.000139	0.000285	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—KIT—breast cancer	0.000136	0.000279	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PIK3CG—breast cancer	0.000136	0.000279	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—APC—breast cancer	0.000136	0.000279	CbGpPWpGaD
Bacitracin—A2M—Metabolism—NOS3—breast cancer	0.000135	0.000277	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—EGF—breast cancer	0.000134	0.000276	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—BRAF—breast cancer	0.000128	0.000262	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PIK3CB—breast cancer	0.000124	0.000256	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—IGF1—breast cancer	0.000124	0.000256	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—AKT2—breast cancer	0.000124	0.000255	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PTGS2—breast cancer	0.000123	0.000253	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PIK3CD—breast cancer	0.000119	0.000245	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—SERPINE1—breast cancer	0.000118	0.000243	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—NOS3—breast cancer	0.000113	0.000232	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PTEN—breast cancer	0.000107	0.000221	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MDM2—breast cancer	0.000107	0.00022	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—RAF1—breast cancer	0.000106	0.000219	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—RELA—breast cancer	0.000106	0.000218	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—ERBB2—breast cancer	0.000105	0.000217	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PIK3CB—breast cancer	0.000104	0.000214	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MTOR—breast cancer	0.000104	0.000214	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CXCL8—breast cancer	9.99e-05	0.000206	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CDKN1B—breast cancer	9.76e-05	0.000201	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CASP3—breast cancer	9.56e-05	0.000197	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—IL2—breast cancer	9.55e-05	0.000196	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CCND1—breast cancer	9.31e-05	0.000191	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—JUN—breast cancer	9.29e-05	0.000191	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CTNNB1—breast cancer	9.22e-05	0.00019	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MMP9—breast cancer	9.04e-05	0.000186	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CDKN1A—breast cancer	9e-05	0.000185	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PTEN—breast cancer	8.98e-05	0.000185	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MAPK8—breast cancer	8.79e-05	0.000181	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—SRC—breast cancer	8.33e-05	0.000171	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—VEGFA—breast cancer	8.11e-05	0.000167	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—STAT3—breast cancer	8.04e-05	0.000165	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MAPK3—breast cancer	7.68e-05	0.000158	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PIK3CA—breast cancer	7.58e-05	0.000156	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MYC—breast cancer	7.47e-05	0.000154	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—TGFB1—breast cancer	7.45e-05	0.000153	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—EGFR—breast cancer	7.3e-05	0.00015	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—KRAS—breast cancer	6.9e-05	0.000142	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PIK3CA—breast cancer	6.34e-05	0.00013	CbGpPWpGaD
Bacitracin—A2M—Metabolism—AKT1—breast cancer	6.19e-05	0.000127	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—TP53—breast cancer	6.13e-05	0.000126	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—HRAS—breast cancer	5.86e-05	0.000121	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—IL6—breast cancer	5.61e-05	0.000115	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—AKT1—breast cancer	5.18e-05	0.000107	CbGpPWpGaD
Bacitracin—Desmopressin—PTGS1—breast cancer	1.03e-05	0.636	CrCbGaD
Bacitracin—Desmopressin—PTGS2—breast cancer	5.87e-06	0.364	CrCbGaD
